Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A McCauley

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Current Topics in Medicinal Chemistry|September 24, 2005
Positive allosteric modulators of the metabotropic glutamate receptor subtype 2 (mGluR2)Michael T Rudd, John A McCauley
Current Opinion in Pharmacology|August 22, 2016
Hepatitis C virus NS3/4a protease inhibitorsJohn A McCauley, Michael T Rudd
Journal of Neuroscience Methods|July 21, 2004
Kinetic characterization of novel NR2B antagonists using fluorescence detection of calcium fluxBohumil Bednar, Michael E Cunningham, Laszlo Kiss, et al.
Neurochemistry International|March 17, 2005
In vitro characterization of novel NR2B selective NMDA receptor antagonistsLaszlo Kiss, Gong Cheng, Bohumil Bednar, et al.
FEMS Microbiology Ecology|July 24, 2012
The mercury resistance (mer) operon in a marine gliding flavobacterium, Tenacibaculum discolor 9A5Rachel C Allen, Yen-Kuei Tu, Michael J Nevarez, et al.
The FEBS Journal|March 4, 2025
Structure-activity analysis of imino-pyrimidinone-fused pyrrolidines aids the development of dual plasmepsin V and plasmepsin X inhibitorsAnthony N Hodder, Brad E Sleebs, Greg Adams, et al.
Antimicrobial Agents and Chemotherapy|October 21, 2009
MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A proteaseNigel J Liverton, Steven S Carroll, Jillian Dimuzio, et al.
Pharmacology Research & Perspectives|March 30, 2016
Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonistRachel Garner, Shobha Gopalakrishnan, John A McCauley, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2009
Synthesis and evaluation of novel tricyclic benzo[4.5]cyclohepta[1.2]pyridine derivatives as NMDA/NR2B antagonistsCharles J McIntyre, John A McCauley, Bohumil Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2007
Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonistsKevin T Nguyen, Christopher F Claiborne, John A McCauley, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Current Topics in Medicinal Chemistry|September 24, 2005
Positive allosteric modulators of the metabotropic glutamate receptor subtype 2 (mGluR2)Michael T Rudd, John A McCauley
Current Opinion in Pharmacology|August 22, 2016
Hepatitis C virus NS3/4a protease inhibitorsJohn A McCauley, Michael T Rudd
Journal of Neuroscience Methods|July 21, 2004
Kinetic characterization of novel NR2B antagonists using fluorescence detection of calcium fluxBohumil Bednar, Michael E Cunningham, Laszlo Kiss, et al.
Neurochemistry International|March 17, 2005
In vitro characterization of novel NR2B selective NMDA receptor antagonistsLaszlo Kiss, Gong Cheng, Bohumil Bednar, et al.
FEMS Microbiology Ecology|July 24, 2012
The mercury resistance (mer) operon in a marine gliding flavobacterium, Tenacibaculum discolor 9A5Rachel C Allen, Yen-Kuei Tu, Michael J Nevarez, et al.
The FEBS Journal|March 4, 2025
Structure-activity analysis of imino-pyrimidinone-fused pyrrolidines aids the development of dual plasmepsin V and plasmepsin X inhibitorsAnthony N Hodder, Brad E Sleebs, Greg Adams, et al.
Antimicrobial Agents and Chemotherapy|October 21, 2009
MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A proteaseNigel J Liverton, Steven S Carroll, Jillian Dimuzio, et al.
Pharmacology Research & Perspectives|March 30, 2016
Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonistRachel Garner, Shobha Gopalakrishnan, John A McCauley, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2009
Synthesis and evaluation of novel tricyclic benzo[4.5]cyclohepta[1.2]pyridine derivatives as NMDA/NR2B antagonistsCharles J McIntyre, John A McCauley, Bohumil Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2007
Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonistsKevin T Nguyen, Christopher F Claiborne, John A McCauley, et al.
Pageof 4